PMEF
KNTE

Point72 Middle East FZE’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Point72 Middle East FZE’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,444
Closed -$28.6K – 1513
2023
Q2 		$28.6K Buy
+9,444
New +$28.6K ﹤0.01% 815
2023
Q1 		– Sell
-1,675
Closed -$10.2K – 1770
2022
Q4 		$10.2K Buy
+1,675
New +$10.2K ﹤0.01% 1175